Home > Healthcare > Medical Devices > Surgical Devices > Resectoscope Devices Market
The global resectoscope devices market size was valued at USD 402.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034 period. The market growth is attributed to the rising prevalence of urological and gynecological disorders and the shift towards minimally invasive procedures.
As conditions such as benign prostatic hyperplasia (BPH) and bladder cancer become more prevalent worldwide, the demand for transurethral resection procedures is on the rise. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 50% of men aged 51 to 60 experience BPH, further driving the need for such procedures. In these minimally invasive treatments, resectoscopes play a crucial role, delivering precision and shortening recovery times in contrast to conventional surgeries.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Resectoscope Devices Market Size in 2024: | USD 402.2 Million |
Forecast Period: | 2025 – 2034 |
Forecast Period 2025 – 2034 CAGR: | 5.7% |
2025 – 2034 Value Projection: | USD 694.4 Million |
Historical Data for: | 2021 – 2024 |
No. of Pages: | 135 |
Tables, Charts & Figures: | 119 |
Segments covered: | Type, Application, End Use, Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Resectoscope devices are specialized medical instruments used primarily in urology and gynecology for performing minimally invasive procedures. These devices are equipped with a light source, irrigation system, and electrosurgical devices, enabling precise resection of tissue from the bladder, prostate, or uterus.